Similar articles for PMID: 29720192

Year	Number of Results
1907	1
1918	2
1958	1
1961	1
1982	1
1990	1
1998	2
1999	3
2000	3
2001	6
2002	6
2003	4
2004	3
2005	2
2006	4
2007	1
2008	7
2009	1
2010	4
2011	11
2012	6
2013	13
2014	14
2015	12
2016	16
2017	17
2018	25
2019	28
2020	19
2021	25
2022	24
2023	13
2024	0

1

The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.

O'Hara J, Walsh S, Camp C, Mazza G, Carroll L, Hoxer C, Wilkinson L. O'Hara J, et al. Health Qual Life Outcomes. 2018 May 2;16(1):84. doi: 10.1186/s12955-018-0908-9. Health Qual Life Outcomes. 2018. PMID: 29720192 Free PMC article.

2

Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.

Booth J, Oladapo A, Walsh S, O'Hara J, Carroll L, Garcia Diego DA, O'Mahony B. Booth J, et al. Haemophilia. 2018 Sep;24(5):e322-e327. doi: 10.1111/hae.13596. Epub 2018 Aug 9. Haemophilia. 2018. PMID: 30091822

3

Social/economic costs and quality of life in patients with haemophilia in Europe.

Cavazza M, Kodra Y, Armeni P, De Santis M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Taruscio D, Schieppati A, Iskrov G, Gulácsi L, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Cavazza M, et al. Eur J Health Econ. 2016 Apr;17 Suppl 1:53-65. doi: 10.1007/s10198-016-0785-2. Epub 2016 Apr 5. Eur J Health Econ. 2016. PMID: 27048374

4

The relationship between target joints and direct resource use in severe haemophilia.

O'Hara J, Walsh S, Camp C, Mazza G, Carroll L, Hoxer C, Wilkinson L. O'Hara J, et al. Health Econ Rev. 2018 Jan 16;8(1):1. doi: 10.1186/s13561-018-0185-7. Health Econ Rev. 2018. PMID: 29340855 Free PMC article.

5

Examining the impact of haemophilia treatment on health-related quality of life.

Shaikh A, Pedra G, Cawson M, Wiseman C. Shaikh A, et al. Haemophilia. 2022 Sep;28(5):796-805. doi: 10.1111/hae.14583. Epub 2022 May 10. Haemophilia. 2022. PMID: 35537107

6

Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.

Burke T, Asghar S, O'Hara J, Chuang M, Sawyer EK, Li N. Burke T, et al. Orphanet J Rare Dis. 2021 Dec 20;16(1):521. doi: 10.1186/s13023-021-02152-1. Orphanet J Rare Dis. 2021. PMID: 34930388 Free PMC article.

7

Association of factor expression levels with health-related quality of life and direct medical costs for people with haemophilia B.

Burke T, Shaikh A, Ali TM, Li N, Curtis R, Garcia Diego DA, Recht M, Sannie T, Skinner M, O'Hara J. Burke T, et al. J Med Econ. 2022 Jan-Dec;25(1):386-392. doi: 10.1080/13696998.2022.2049552. J Med Econ. 2022. PMID: 35253589 Free article.

8

Rodriguez-Santana I, DasMahapatra P, Burke T, Hakimi Z, Bartelt-Hofer J, Nazir J, O'Hara J. Rodriguez-Santana I, et al. Orphanet J Rare Dis. 2022 Apr 4;17(1):150. doi: 10.1186/s13023-022-02301-0. Orphanet J Rare Dis. 2022. PMID: 35379284 Free PMC article.

9

Comparing the Quality of Life of Patients With Hemophilia and Juvenile Idiopathic Arthritis in Which Chronic Arthropathy Is a Common Complication.

Oymak Y, Kaygusuz A, Turedi A, Yaman Y, Eser E, Cubukcu D, Vergin C. Oymak Y, et al. J Pediatr Hematol Oncol. 2015 Nov;37(8):600-4. doi: 10.1097/MPH.0000000000000429. J Pediatr Hematol Oncol. 2015. PMID: 26479992

10

The cost of severe haemophilia in Europe: the CHESS study.

O'Hara J, Hughes D, Camp C, Burke T, Carroll L, Diego DG. O'Hara J, et al. Orphanet J Rare Dis. 2017 May 31;12(1):106. doi: 10.1186/s13023-017-0660-y. Orphanet J Rare Dis. 2017. PMID: 28569181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

242 results

Results by year